Cargando…
Is the neutrophil-to-lymphocyte ratio a useful prognostic indicator in melanoma patients?
The neutrophil-to-lymphocyte ratio (NLR) is gaining traction as a biomarker with utility in a variety of malignancies including melanoma. Intact lymphocyte function is necessary for tumor surveillance and destruction, and neutrophils play a role in suppressing lymphocyte proliferation and in the ind...
Autores principales: | Cohen, Joshua T, Miner, Thomas J, Vezeridis, Michael P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475797/ https://www.ncbi.nlm.nih.gov/pubmed/32922729 http://dx.doi.org/10.2217/mmt-2020-0006 |
Ejemplares similares
-
Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio reliable parameters as prognostic indicators in malignant mesothelioma?
por: Tural Onur, Seda, et al.
Publicado: (2016) -
The Prognostic Significance of Baseline Neutrophil-to-Lymphocyte Ratio in Melanoma Patients Receiving Immunotherapy
por: Li, Yayun, et al.
Publicado: (2022) -
Role of neutrophil to lymphocyte ratio as a prognostic indicator for COVID‐19
por: Amer, Samar A., et al.
Publicado: (2021) -
Prognostic role of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with bone metastases
por: Thio, Quirina C. B. S., et al.
Publicado: (2018) -
Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis
por: Bowen, Randy C., et al.
Publicado: (2017)